Literature DB >> 8537027

Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme.

B J Glasgow1.   

Abstract

BACKGROUND: Tear-specific prealbumin is a group of proteins recently renamed as the tear lipocalins. These proteins were initially described as unique to lacrimal fluid. The tissue distribution and localization have never been thoroughly studied.
METHODS: The distribution of purified tear lipocalins was studied in many human secretions and tissues by western blots, immunohistochemistry and immunoelectron microscopy.
RESULTS: Tear lipocalin species of the same molecular weights were observed in western blot lanes loaded with tears, saliva, and protein extracts from the lacrimal and lingual von Ebner's glands. Lacrimal and von Ebner's glands contained tear lipocalins; other human tissues and secretions, including other salivary glands and taste buds, did not. Tear lipocalins colocalized with lysozyme in serous acinar cells of lacrimal and von Ebner's glands. Ultrastructurally, tear lipocalins were present on polyribosomes, endoplasmic reticulum, and Golgi areas. Lipocalins were concentrated in lacrimal secretory granules in amounts commensurate with a regulated pathway.
CONCLUSION: Tear lipocalins are expressed and truncated similarly in lingual von Ebner's and lacrimal glands, but not at all in other human tissues. Lipocalins are expressed and secreted with lysozyme. Lipocalins are concentrated in secretory granules in an amount consistent with a regulated secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537027     DOI: 10.1007/bf00183433

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  New members of the lipocalin family in human tear fluid.

Authors:  A Delaire; H Lassagne; A M Gachon
Journal:  Exp Eye Res       Date:  1992-10       Impact factor: 3.467

2.  Specific tear prealbumin: a unique lachrymal protein absent from serum and other secretions.

Authors:  B Bonavida; A T Sapse; E E Sercarz
Journal:  Nature       Date:  1969-01-25       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Constitutive and regulated secretion of proteins.

Authors:  T L Burgess; R B Kelly
Journal:  Annu Rev Cell Biol       Date:  1987

5.  Assignment of the human tear lipocalin gene (LCN1) to 9q34 by in situ hybridization.

Authors:  H Lassagne; C Ressot; M G Mattei; A M Gachon
Journal:  Genomics       Date:  1993-10       Impact factor: 5.736

6.  Origin and biosynthesis of human tear fluid proteins.

Authors:  P T Janssen; O P van Bijsterveld
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-05       Impact factor: 4.799

7.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03

8.  Immunohistochemical characterization of epithelial cells in human lacrimal glands. II. Inflammatory and neoplastic lesions of lacrimal glands.

Authors:  C M Wilk; N Vigneswaran; A Heese; O P Hornstein; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

9.  The lacrimal gland synthesizes retinol-binding protein.

Authors:  S Y Lee; J L Ubels; D R Soprano
Journal:  Exp Eye Res       Date:  1992-07       Impact factor: 3.467

View more
  31 in total

1.  Excited protein states of human tear lipocalin for low- and high-affinity ligand binding revealed by functional AB loop motion.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biophys Chem       Date:  2010-04-09       Impact factor: 2.352

2.  Interaction of phospholipid transfer protein with human tear fluid mucins.

Authors:  Niko L Setälä; Juha M Holopainen; Jari Metso; Gebrenegus Yohannes; Jaakko Hiidenhovi; Leif C Andersson; Ove Eriksson; Alexandra Robciuc; Matti Jauhiainen
Journal:  J Lipid Res       Date:  2010-08-19       Impact factor: 5.922

3.  Characterization of fluorescence of ANS-tear lipocalin complex: evidence for multiple-binding modes.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Photochem Photobiol       Date:  2007 Nov-Dec       Impact factor: 3.421

4.  Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 Glycocalyx.

Authors:  Ben J Glasgow; Oktay K Gasymov; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

5.  Effect of short- and long-range interactions on trp rotamer populations determined by site-directed tryptophan fluorescence of tear lipocalin.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

6.  pH-Dependent conformational changes in tear lipocalin by site-directed tryptophan fluorescence.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

7.  Gene expression in human accessory lacrimal glands of Wolfring.

Authors:  John L Ubels; Ilene K Gipson; Sandra J Spurr-Michaud; Ann S Tisdale; Rachel E Van Dyken; Mark P Hatton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

8.  Ligand binding complexes in lipocalins: Underestimation of the stoichiometry parameter (n).

Authors:  Ben J Glasgow; Adil R Abduragimov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-07-07       Impact factor: 3.036

9.  A simple model-free method for direct assessment of fluorescent ligand binding by linear spectral summation.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Ben J Glasgow
Journal:  J Fluoresc       Date:  2013-09-18       Impact factor: 2.217

10.  Tear lipocalin captures exogenous lipid from abnormal corneal surfaces.

Authors:  Ben J Glasgow; Oktay K Gasymov; Adil R Abduragimov; Jamison J Engle; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.